1,204
Participants
Start Date
February 16, 2023
Primary Completion Date
July 28, 2025
Study Completion Date
July 28, 2025
Edoxaban
This is observational, non-interventional study. No study drug will be administered during this study.
National Health Insurance Service Ilsan Hospital, Goyang
Seoul National University Bundang Hospital, Seongnam
Korea University Ansan Hospital, Ansan
Catholic University of Korea St. Vincent's Hospital, Suwon
Gachon University Gil Medical Center, Incheon
Kangwon National University Hospital, Chuncheon
Wonju Severance Christian Hospital, Wŏnju
Dankook University Hospital, Cheonan
Soonchunhyang University Hospital, Cheonan
Catholic University of Korea Daejeon St. Mary's Hospital, Daejeon
Chungnam University Hospital, Daejeon
Keimyung University Dongsan Medical Center, Daegu
Ulsan University Hospital, Ulsan
Dong-A University Hospital, Busan
Pusan National University Hospital, Busan
Samsung Changwon Center, Changwon
Gyeongsang National University Hospital, Jinju
Wonkwang University Hospital, Iksan
Chosun University Hospital, Gwangju
Chonnam Natinal University Hospital, Gwangju
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Severance Hospital, Seoul
KyungHee University Hospital at GangDong, Seoul
Korea Veterans Health Medical Center, Seoul
Asan Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Samsung Medical Center, Seoul
Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Chung-Ang University Hosptial, Seoul
Ewha Womans University Seoul Hospital, Seoul
Korea University Guro Hospital, Seoul
Lead Sponsor
Daiichi Sankyo Korea Co., Ltd.
INDUSTRY
Daiichi Sankyo
INDUSTRY